Discovery Discovery platform from Ai Ai Alphabet, $ 600 million, from Thrive

Symptoms, the platform for the detection of the artificial intelligence drugs that were Spun from Google’s DeepMind In 2021, she raised the outer capital for the first time. It led a round of $ 600 million by Thrive Capital, with the participation of the GV, the current investor, the father, Google, He said.

This funding will accelerate the development of the AI ​​ISOMORPHIC pharmaceutical engine and supports the company’s goal of providing discovered drugs to clinical trials.

Isomorphic Labs was established by the co -founder of Deepmind Demis Hassabis by taking advantage of DeepMind to discover artificial intelligence drugs, including Alphafold, a model of artificial intelligence that predicts 3D proteins.

Last year, similar laboratories got strategic partnerships with Eli Lilly and Novartis, may be Establishing up to 3 billion dollars In the teacher’s payments to reach the artificial intelligence model.

Hassan said New York Times While Labs Isomorphic did not need capital, additional financing will help the department employ senior research scientists.

For their work in Alphafold, Hassabis and DeepMind, John John was among the three scientists who received a Nobel Prize in Chemistry In 2024.